Results 151 to 160 of about 118,712 (218)

Accelerated Combinatorial Drug Design for Human Immunodeficiency Virus Resistance through Seeded Multisite λ-Dynamics. [PDF]

J Chem Theory Comput
Bowling PE, Vilseck JZ, Brooks CL.
europepmc   +1 more source

Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment. [PDF]

ACS Omega
Martinez DP, Kremer FS.
europepmc   +1 more source

Characterization of human immunodeficiency virus drug-resistance mutations among individuals with low-level-viremia in low-income and middle-income countries: A meta-analysis. [PDF]

World J Virol
El-Imam IA, Chenya UK, Mbishi JV, Peter TA, Mpimo BK, Ndembi N, Bakari HM, Mbwana MS, Fussi HF, Ally HM, Dababneh SW, Ramadhani HO.   +11 more
europepmc   +1 more source

Protease-mediated maturation of M-PMV reverse transcriptase into a functional heterodimer. [PDF]

Protein Sci
Kapisheva M, Junková P, Vaněk O, Jalovcová Z, Křížová I, Dostálková A, Rumlová M.   +6 more
europepmc   +1 more source

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

Euro Surveill
van Kampen J, Voermans J, Soochit W, Mesplède T, van de Laar T, van der Reijden W, Burger D, Shalev N, van Sighem A, Bezemer D, Jurriaans S, van der Vaart T, de Jong H, van der Valk M.   +13 more
europepmc   +1 more source

Characteristics of Drug Resistance Mutations in a Korean HIV/AIDS Cohort, and Risk Factors for Resistance Acquisition in ART-Experienced Patients. [PDF]

Infect Chemother
Lee M, Kim SM, Kim JH, Park BY, Choi JY, Kim JH, Kim YK, Kim SI, Kim SW, Hur J, Kim Y, Choi HJ, Song JY, Jeong O, Go MJ, Ryou S, Kim HS, Jeong HW.   +17 more
europepmc   +1 more source

Marine-Derived Defenses Against HIV: Emerging Bioactive Molecules from the Seas. [PDF]

Mar Drugs
Santos T, Pintão A, Marques CS, Brandão P.   +3 more
europepmc   +1 more source

Efficacy of dolutegravir-based therapy in achieving virological suppression in PLHIV in low- and middle-income countries: real-world evidence from a large clinical cohort in Cameroon. [PDF]

BMC Infect Dis
Tadenfok C, Fokam J, Semengue ENJ, Mossiang L, Oyie S, Noumo P, Ngia J, Beloumou GA, Djupsa Ndjeyep SC, Nka AD, Chenwi Ambe C, Ka'e AC, Takou D, Ngwese DTA, Anim-Keng TT, Forgwei L, Kengne A, Yagai B, Elong Lobe E, Feukeng A, Awoh RA, Bissek AZ, Vouking M, Ndjolo A, Ndembi N, Perno CF, Kouanfack C, Nkenfou C.   +27 more
europepmc   +1 more source

Modeling NRTIs and PIs class drug therapy on the dynamics of HIV infection with real patient data analysis and optimized control strategy. [PDF]

Sci Rep
Sardar P, Ranjit B, Biswas S, Boulaaras SM, Allali K, Pal B, Das KP.   +6 more
europepmc   +1 more source

Individualized immunotherapy for immune reconstitution-associated cortical encephalitis in an HIV-positive cryptococcal meningitis patient: a case report. [PDF]

Front Immunol
Wang W, Tang S, Yang J, Wen Y.
europepmc   +1 more source